
Oncologist

No OPD information available
Colorectal Cancer
Neuroendocrine Tumor
Pancreatic Cancer
Pancreatic Ductal Adenocarcinoma
Embryonal Tumor with Multilayered Rosettes
Esophageal Cancer
Familial Colorectal Cancer
Gallbladder Adenocarcinoma
Gastroesophageal Junction Cancer
Heart Tumor
Lung Metastases
Melanoma
Pancreatic Islet Cell Tumor
Turcot Syndrome
Vulvar Cancer
Matthew E. Burge is a male doctor who helps people with different types of cancer like colorectal cancer, pancreatic cancer, and melanoma. He is very skilled in treating these diseases. He also works with patients who have heart tumors, lung metastases, and other serious conditions.
Dr. Burge is good at talking to his patients and making them feel comfortable. People trust him because he listens to their concerns and explains things clearly. He is kind and caring, which helps patients feel safe and supported during their treatment.
To make sure he gives the best care, Dr. Burge stays up-to-date with the latest medical knowledge and research. This means he is always learning new things to help his patients even more. He works closely with other doctors and medical professionals to share ideas and improve the way they care for people.
One of Dr. Burge's important studies was about treating colorectal cancer. He found a better way to help older patients with this type of cancer. This study was published in a medical journal called Clinical Colorectal Cancer. He is also involved in a clinical trial to study a new treatment for advanced gastro-esophageal cancer.
Dr. Burge's work has made a big difference in the lives of many patients. His treatments have helped people feel better and live longer. He is dedicated to finding new ways to fight cancer and improve the health of those he cares for.
In summary, Dr. Matthew E. Burge is a caring and skilled doctor who specializes in treating different types of cancer. He stays informed about the latest medical advancements, works well with other medical professionals, and has made a positive impact on his patients' lives through his research and treatments.
Enrollment Status: Active not recruiting
Published: May 16, 2024
Intervention Type: Drug, Biological
Study Drug:
Study Phase: Phase 3
